Trials / Conditions / Primary Immunodeficiency Disease

Primary Immunodeficiency Disease

10 registered clinical trials studyying Primary Immunodeficiency Disease.

Status	Trial	Sponsor	Phase
Unknown	Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG NCT06089122	Azidus Brasil	Phase 3
Unknown	Efficacy and Safety and Pharmacokinetics of Boya IVIG NCT06150833	Azidus Brasil	Phase 3
Completed	An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease NCT04842643	Takeda	Phase 3
Active Not Recruiting	Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES1 NCT04944979	Kedrion S.p.A.	Phase 3
Completed	Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients NCT03961009	Kedrion S.p.A.	Phase 3
Unknown	Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment NCT03677557	Ottawa Hospital Research Institute	Phase 4
Unknown	Pediatric Primary Immunodeficiency Disease (PID) in China NCT03252548	Beijing Children's Hospital	—
Completed	Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID NCT02810444	Biotest	Phase 3
Completed	High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam) NCT01313507	Octapharma	Phase 3
Unknown	Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland NCT01150240	University of Zurich	—